Early structural valve deterioration and reoperation associated with the mitroflow aortic valve.

Andrea L AxtellDavid C ChangSerguei MelnitchoukArminder S JassarGeorge TolisMauricio A VillavicencioThoralf M SundtDavid A D'Alessandro

Published in: Journal of cardiac surgery (2018)

The Mitroflow aortic bioprosthesis is associated with increased rates of early SVD and reoperation for valvular dysfunction as well as reduced survival compared to a contemporary valve. Enhanced clinical and echocardiographic follow-up is advisable after Mitroflow implantation.

Keyphrases

aortic valve
transcatheter aortic valve replacement
aortic valve replacement
aortic stenosis
transcatheter aortic valve implantation
mitral valve
oxidative stress
left ventricular
pulmonary hypertension
atrial fibrillation